FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

PEGINTRON (peginterferon alfa-2b) REDIPEN
Status: Discontinuation
»Therapeutic Categories: Antiviral

Expand all

Merck Sharp & Dohme Corp. (New 03/18/2015)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
A box containing one and a box containing one 80 mcg per 0.5 mL PegIntron REDIPENs and 1 BD needle and 2 alcohol swabs. (NDC 0085-1316-01) 03/18/2015 PegIntron 80 mcg Vials will remain on the market. (NDC 0085-1291-01)
Dear Health Care Professional
A box containing one and a box containing one 120 mcg per 0.5 mL PegIntron REDIPENs and 1 BD needle and 2 alcohol swabs. (NDC 0085-1297-01) 03/18/2015 PegIntron 120 mcg Vials will remain on the market. (NDC 0085-1304-01)
Dear Health Care Professional
A box containing one and a box containing one 150 mcg per 0.5 mL PegIntron REDIPENs and 1 BD needle and 2 alcohol swabs. )NDC 0085-1370-01) 03/18/2015 PegIntron 150 mcg Vials will remain on the market. (NDC 0085-1279-01)
Dear Health Care Professional
A box containing one and a box containing one 50 mcg per 0.5 mL PegIntron REDIPENs and 1 BD needle and and 2 alcohol swabs. (NDC 0085-1323-01) 03/18/2015 PegIntron 50 mcg Vials will remain on the market. (NDC 0085-1368-01)
Dear Health Care Professional

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English